Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Effect of atorvastatin on the metabolic syndrome of polycystic ovary syndrome.

Trial Profile

Effect of atorvastatin on the metabolic syndrome of polycystic ovary syndrome.

Completed
Phase of Trial: Phase II

Latest Information Update: 18 Jun 2013

At a glance

  • Drugs Atorvastatin (Primary)
  • Indications Polycystic ovary syndrome
  • Focus Therapeutic Use
  • Acronyms PAT
  • Most Recent Events

    • 18 Jun 2013 Results presented at the 95th Annual Meeting of the Endocrine Society.
    • 05 Jun 2008 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top